Skip to main content
. Author manuscript; available in PMC: 2013 Feb 15.
Published in final edited form as: Clin Cancer Res. 2012 Jan 6;18(4):1039–1050. doi: 10.1158/1078-0432.CCR-11-1429

Figure 3. CD20 knockdown in Raji only partially decreased rituximab-associated CMC.

Figure 3

Endogenous CD20 in Raji cells were knocked down using On-Targetplus SMARTpool siRNA against CD20 (MS4A1), which consisted of 4 siRNA duplexes. Cell lysates were prepared for (A) Western blot analysis to detect endogenous expression of CD20. (B) Quantification of Western blot analysis by Image J software. (C) Comparison of surface CD20 density and rituximab-associated CMCin Raji and Raji2R.